Titan Pharmaceuticals
TTNP
#11013
Rank
HK$48.1 M
Marketcap
HK$36.16
Share price
-3.76%
Change (1 day)
17.17%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -HK$34.26

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$34.44. In 2023 the company made an earnings per share (EPS) of -HK$58.13 an increase over its 2022 EPS that were of -HK$119.16.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$34.26
2023-HK$58.13-51.22%
2022-HK$119.16-15.61%
2021-HK$141.20-81.37%
2020-HK$757.77-77.52%
2019-HK$3,372-56.32%
2018-HK$7,719-59.51%
2017-HK$19,066-371.81%
2016HK$7,014-144.35%
2015-HK$15,814300%
2014-HK$3,954-121.54%
2013HK$18,356-151.38%
2012-HK$35,724-11.54%
2011-HK$40,383188.89%
2010-HK$13,979-10%
2009-HK$15,532
2007-HK$63,681-2.38%
2006-HK$65,235-39.13%
2005-HK$107,171-16.87%
2004-HK$128,916-22.43%
2003-HK$166,1934.9%
2002-HK$158,42761.9%
2001-HK$97,852-13.7%
2000-HK$113,38465.01%
1999-HK$68,715-35.87%
1998-HK$107,153-1824.71%
1997HK$6,213-102.4%
1996-HK$259,385

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.52-298.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$55.07-259.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-HK$31.77-7.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
HK$7.22-120.96%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-HK$1.88-94.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$33.42-2.96%๐Ÿ‡บ๐Ÿ‡ธ USA